The Latest Cardiac and Vascular News
Allschwil, Switzerland – June 20, 2018 Idorsia Ltd (SIX: IDIA) today announced that the first patient has been enrolled into PRECISION, a Phase 3 study to investigate the efficacy and safety of aprocitentan for resistant hypertension management in adults. Hypertension, or high blood pressure, remains the most frequent addressable risk […]
Tel Aviv, Israel, June 20, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that CGuard™ EPS was featured at the SBHCI Congress, sponsored by the Brazilian Society of Hemodynamics and Interventional Cardiology, which took […]
IRVINE, Calif., June 20, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, today announced that it has selected Fundación Santa Fe de Bogotá (“FSFB”), in Bogota Columbia, as the […]
STAMFORD, Conn. and BOTHELL, Wash., June 20, 2018 /PRNewswire/ — (Booth #414) – FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite, Inc., will bring their collective cardiovascular medical imaging portfolio to the American Society of Echocardiography’s (ASE) 29th Annual Scientific Sessions, taking place June 22 – 26, 2018 in Nashville, TN.During the scientific sessions Fujifilm will provide the technology to support a point-of-care ultrasound […]
ATLANTA, June 19, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, today announced the appointment of Marna Borgstrom to its Board of Directors effective immediately. Pat Mackin, Chairman, President, and Chief Executive Officer, commented, “Marna has nearly 40 years of escalating senior leadership experience at Yale New […]
VANCOUVER, June 20, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, today announced the first U.S. patient has been implanted with a Neovasc Reducer™ (the “Reducer”), a CE-Marked medical device for the treatment of refractory […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., a developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced initiation of patient enrollment and implantations associated with the CE Mark study of its next generation JenaValve Pericardial TAVR System using the CoronatixTM Transfemoral Delivery Catheter for the percutaneous treatment of patients […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it has appointed Douglas Teany, currently the company’s Senior Vice President of R&D and Operations, to Chief Operating Officer, effective immediately. Teany brought eighteen years of experience to Corindus, driving operational excellence […]
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Humacyte, an innovator in biotechnology and regenerative medicine, announced today that Jeffrey Lawson MD, PhD has been appointed President and Chief Executive Officer. Carrie S. Cox has assumed the role of Executive Chairman. Dr. Lawson, an innovator, scientist and vascular surgeon has been involved in the […]
GENT, Belgium–(BUSINESS WIRE)–FEops, the leader in personalized computational modeling and simulation for structural heart interventions, today announced the expansion of its management team with the appointments of Christian Vincent as Director of Therapy Development and Nico Uwents as Director of Business Development. “Both Christian and Nico have a long track record of success in […]
